Your browser doesn't support javascript.
loading
SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
Alghamdi, Abdullah S; Alghamdi, Hamdan; Alserehi, Haleema A; Babatin, Mohammed A; Alswat, Khalid A; Alghamdi, Mohammed; AlQutub, Adel; Abaalkhail, Faisal; Altraif, Ibrahim; Alfaleh, Faleh Z; Sanai, Faisal M.
Afiliación
  • Alghamdi AS; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia.
  • Alghamdi H; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alserehi HA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Babatin MA; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Alswat KA; General Directorate of Communicable Diseases, Ministry of Health, Riyadh, Saudi Arabia.
  • Alghamdi M; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia.
  • AlQutub A; Liver Disease Research Center, and Riyadh, Saudi Arabia.
  • Abaalkhail F; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Altraif I; Department of Medicine, Division of Gastroenterology, King Fahd Military Complex, Dhahran, Saudi Arabia.
  • Alfaleh FZ; Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Sanai FM; Department of Medicine, Section of Gastroenterology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Saudi J Gastroenterol ; 30(Supp 1): S1-S42, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-38167232
ABSTRACT
ABSTRACT Hepatitis C virus (HCV) infection has been a major global health concern, with a significant impact on public health. In recent years, there have been remarkable advancements in our understanding of HCV and the development of novel therapeutic agents. The Saudi Society for the Study of Liver Disease and Transplantation formed a working group to develop HCV practice guidelines in Saudi Arabia. The methodology used to create these guidelines involved a comprehensive review of available evidence, local data, and major international practice guidelines regarding HCV management. This updated guideline encompasses critical aspects of HCV care, including screening and diagnosis, assessing the severity of liver disease, and treatment strategies. The aim of this updated guideline is to assist healthcare providers in the management of HCV in Saudi Arabia. It summarizes the latest local studies on HCV epidemiology, significant changes in virus prevalence, and the importance of universal screening, particularly among high-risk populations. Moreover, it discusses the promising potential for HCV elimination as a public health threat by 2030, driven by effective treatment and comprehensive prevention strategies. This guideline also highlights evolving recommendations for advancing disease management, including the treatment of HCV patients with decompensated cirrhosis, treatment of those who have previously failed treatment with the newer medications, management in the context of liver transplantation and hepatocellular carcinoma, and treatment for special populations.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hepatitis C / Hepatitis C Crónica / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Saudi J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Hígado / Hepatitis C / Hepatitis C Crónica / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Saudi J Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: India